Linden A Green1, Victor Njoku2, Julie Mund2, Jaime Case2, Mervin Yoder2, Michael P Murphy2, Matthias Clauss2. 1. From the Department of Cellular and Integrative Physiology, RLR VA Medical Center, and Indiana Center for Vascular Biology and Medicine (L.A.G., M.P.M., M.C.), Department of Pediatrics (M.Y.), Department of Surgery (V.N., M.P.M.), and Department of Pediatrics, Herman B Wells Center for Pediatric Research, and Indiana University Simon Cancer Center (J.M., J.C.), Indiana University School of Medicine, Indianapolis; and Biomedical Sciences, University of Ulster, Coleraine, United Kingdom (M.C.). lihorton@indiana.edu. 2. From the Department of Cellular and Integrative Physiology, RLR VA Medical Center, and Indiana Center for Vascular Biology and Medicine (L.A.G., M.P.M., M.C.), Department of Pediatrics (M.Y.), Department of Surgery (V.N., M.P.M.), and Department of Pediatrics, Herman B Wells Center for Pediatric Research, and Indiana University Simon Cancer Center (J.M., J.C.), Indiana University School of Medicine, Indianapolis; and Biomedical Sciences, University of Ulster, Coleraine, United Kingdom (M.C.).
Abstract
RATIONALE: Transmembrane tumor necrosis factor-α (tmTNF-α) is the prime ligand for TNF receptor 2, which has been shown to mediate angiogenic and blood vessel repair activities in mice. We have previously reported that the angiogenic potential of highly proliferative endothelial colony-forming cells (ECFCs) can be explained by the absence of senescent cells, which in mature endothelial cells occupy >30% of the population, and that exposure to a chronic inflammatory environment induced premature, telomere-independent senescence in ECFCs. OBJECTIVE: The goal of this study was to determine the role of tmTNF-α in the proliferation of ECFCs. METHODS AND RESULTS: Here, we show that tmTNF-α expression on ECFCs selects for higher proliferative potential and when removed from the cell surface promotes ECFC senescence. Moreover, the induction of premature senescence by chronic inflammatory conditions is blocked by inhibition of tmTNF-α cleavage. Indeed, the mechanism of chronic inflammation-induced premature senescence involves an abrogation of tmTNF/TNF receptor 2 signaling. This process is mediated by activation of the tmTNF cleavage metalloprotease TNF-α-converting enzyme via p38 MAP kinase activation and its concurrent export to the cell surface by means of increased iRhom2 expression. CONCLUSIONS: Thus, we conclude that tmTNF-α on the surface of highly proliferative ECFCs plays an important role in the regulation of their proliferative capacity.
RATIONALE: Transmembrane tumor necrosis factor-α (tmTNF-α) is the prime ligand for TNF receptor 2, which has been shown to mediate angiogenic and blood vessel repair activities in mice. We have previously reported that the angiogenic potential of highly proliferative endothelial colony-forming cells (ECFCs) can be explained by the absence of senescent cells, which in mature endothelial cells occupy >30% of the population, and that exposure to a chronic inflammatory environment induced premature, telomere-independent senescence in ECFCs. OBJECTIVE: The goal of this study was to determine the role of tmTNF-α in the proliferation of ECFCs. METHODS AND RESULTS: Here, we show that tmTNF-α expression on ECFCs selects for higher proliferative potential and when removed from the cell surface promotes ECFC senescence. Moreover, the induction of premature senescence by chronic inflammatory conditions is blocked by inhibition of tmTNF-α cleavage. Indeed, the mechanism of chronic inflammation-induced premature senescence involves an abrogation of tmTNF/TNF receptor 2 signaling. This process is mediated by activation of the tmTNF cleavage metalloprotease TNF-α-converting enzyme via p38 MAP kinase activation and its concurrent export to the cell surface by means of increased iRhom2 expression. CONCLUSIONS: Thus, we conclude that tmTNF-α on the surface of highly proliferative ECFCs plays an important role in the regulation of their proliferative capacity.
Authors: M Clauss; C Sunderkötter; B Sveinbjörnsson; S Hippenstiel; A Willuweit; M Marino; E Haas; R Seljelid; P Scheurich; N Suttorp; M Grell; W Risau Journal: Blood Date: 2001-03-01 Impact factor: 22.113
Authors: Rajesh S Alphonse; Arul Vadivel; Moses Fung; William Chris Shelley; Paul John Critser; Lavinia Ionescu; Megan O'Reilly; Robin K Ohls; Suzanne McConaghy; Farah Eaton; Shumei Zhong; Merv Yoder; Bernard Thébaud Journal: Circulation Date: 2014-04-07 Impact factor: 29.690
Authors: M Grell; E Douni; H Wajant; M Löhden; M Clauss; B Maxeiner; S Georgopoulos; W Lesslauer; G Kollias; K Pfizenmaier; P Scheurich Journal: Cell Date: 1995-12-01 Impact factor: 41.582
Authors: Jieun Lee; Nazish Sayed; Arwen Hunter; Kin Fai Au; Wing H Wong; Edward S Mocarski; Renee Reijo Pera; Eduard Yakubov; John P Cooke Journal: Cell Date: 2012-10-26 Impact factor: 41.582
Authors: Sarvesh Chelvanambi; Samir K Gupta; Xingjuan Chen; Bradley W Ellis; Bernhard F Maier; Tyler M Colbert; Jithin Kuriakose; Pinar Zorlutuna; Paul Jolicoeur; Alexander G Obukhov; Matthias Clauss Journal: Circ Res Date: 2019-08-27 Impact factor: 17.367
Authors: Diane R Wagner; Sonali Karnik; Zachary J Gunderson; Jeffery J Nielsen; Alanna Fennimore; Hunter J Promer; Jonathan W Lowery; M Terry Loghmani; Philip S Low; Todd O McKinley; Melissa A Kacena; Matthias Clauss; Jiliang Li Journal: World J Stem Cells Date: 2019-06-26 Impact factor: 5.326
Authors: Abidemi Junaid; Johannes Schoeman; Wei Yang; Wendy Stam; Alireza Mashaghi; Anton Jan van Zonneveld; Thomas Hankemeier Journal: Elife Date: 2020-08-04 Impact factor: 8.140